• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/78

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

78 Cards in this Set

  • Front
  • Back
Acute Lymphoblastic Leukemia: Epi
77% of all childhood leukemias
Acute Lymphoblastic Leukemia: Initial presentation
Nonspecific, brief onsent
*Fever, anorexia, fatigue
* Bone and joint pain (1/4), especially lower extremities
Acute Lymphoblastic Leukemia: Later Signs/Sx
1. Bone marrow failure: pallor, brusing, epistaxis
2. Petechiae, purpura, mucous membrane bleeding, LAD, HSM, joint swelling
Acute Lymphoblastic Leukemia: Key to Bone/Joint Pain
1/4 ALL patients present this way so have to keep this in the differential for bone/joint pain
Acute Lymphoblastic Leukemia: LAD distribution
- Suprclavicular and axillary are more suspicious
Acute Lymphoblastic Leukemia: Dx Tests
1. Peripheral Blood
2. BM aspirate
Acute Lymphoblastic Leukemia: Peripheral blood findings
a. anemia
b. thrombocytopenia
c. OFTEN do not see malignant cells
d. Most WBC < 10k --> Atypical lymphocytes
Acute Lymphoblastic Leukemia: BM findings
- Lymphoblasts
Acute Lymphoblastic Leukemia: Tx
1. Remission Induction
2. CNS Treatment (Phase 2)
3. Maintenance
Acute Lymphoblastic Leukemia: Remission Rates
98% in 4-5w
Acute Lymphoblastic Leukemia: CNS Treatment
Intrathecal and intensive systemic --> Decreases CNS relapse rate to 5%

For all ALL b/c ALL likes to hide in CNS (And testes)
Acute Lymphoblastic Leukemia: Maintenance phase time
2-3y
*Includes intrathecal therapy as well
Acute Lymphoblastic Leukemia: What Tx NOT used
*Radiation: Poor brain penetration, hard to irradiate all of blood...
*Many side effects
Acute Lymphoblastic Leukemia: Complications
1. Major impediment is relapse
2. Pneumocytis carinii
3. Other infections
Acute Lymphoblastic Leukemia: Relapse Rates and Sites/Characteristics
*15-20% overall
*Increased ICP or isolated CN palsies
* Testicular relapse in 1-2% of boys
Acute Lymphoblastic Leukemia: Tumor Lysis Syndrome
*No exclusive to this --> but any large tumor load (high WBC count > 50K or so

a. Hyperuricemia
b. electrolyte imbalance, K, P, Ca
c. Renal failure
Acute Lymphoblastic Leukemia: Tumor Lysis syndrome Tx
1. Hydration BEFORE and after
2. alkalinize urine
3. Prevent uric acid formation (pharm)
Acute Lymphoblastic Leukemia: Prognosis
VERY Good
1. > 80% 5-year
Acute Lymphoblastic Leukemia: Bad prognostic factors
1. Age < 1 or > 10y at Dx
2. > 100k WBC
3. Slow initial reponse
4. Chromosomal abnormalities
Hodgkins Disease: Age Range
Ages 15-19 (And another ~ 50y)
Hodgkins Disease: Histo
Reed-Sternberg Cell: Large cell w/ multilobulated nuclei

*Four subtypes
Hodgkins Disease: Possible etiology
EBV (But more associated with NHL)
Immunodeficiencies do predispose
Hodgkins Disease: Presentation
*Depends on tumor location
1. Painless, firm, cervical or supraclavicular nodes (#1)
2. Anterior mediastinal mass
3. Night sweats, fever, weight loss, lethargy, anorexia, pruritus (ITCHING)
Hodgkins Disease: Dx
BEST: Bx of affected node
Hodgkins Disease: Staging Tests
CXR (All patient to look for mets)
CBC
ESR, ferritin, Copper
CT Chest abdomen
Bone Marrow if III/IV
Hodgkins Disease: Staging
I: Single node/site
II: Two+ nodes but same side diaphragm
III: Both side diaphragm
IV: Diffuse
Hodgkins Disease: Tx Determined by
1. Disease stage, patient age
2. Size of mass
3. Hilar nodes
Hodgkins Disease: Tx modalities
Chemo
Radiation
NHL: Origins
*Malignant proliferation of lymphocytes: T, B, or intermediate origin
NHL: Ages vs. Hodgkins
- Younger
NHL: Possible etiology
EBC - Major role in Burkitts
1. 95% EBV genome in equatorial africa
2. Also congenital or acquired immunodeficiency predispose
NHL: Subtypes
1. Lymphoblastic -- Usually T
2. Small, noncleaved cell lymphoma -- B
3. Large Cell -- T, B, Intermediate
NHL: Presentation
*Depends on Locations
1. Anterior Mediastinal mass = respiratory Sx
2. Abdominal pain, mass, possible constipation
NHL: Dx
- Prompt b/c it's a very aggressive disease
1. Bx
2. Noninvasive: CT, CXR, Etc
NHL: St. Jude Staging System
I. Localized
II. Regional w/o mediastinal
III. Mediastinal/extensive
IV. Disseminated
NHL: Tx
1. Surgical excision of tumor if accessible
2. Chemo: To shrink
3. Radiation for some
NHL: Cure Rate
90% at 5-y for I and II
Most common solid tumors in children
Brain tumors (combined) -- 2nd most common cancers overall
Brain Tumors: Mortality
45% (Also highest morbidity)
Brain Tumors: Age Range
Most < 7y
Brain Tumors: Sites
2/3 are infratentorial
Suspected Brain Tumors: Best initial Test
Head CT
Brain Tumors Location + Type: 0-1y
Supratentorial
*Choroid Plexus + Teratomas
Brain Tumors Location + Type: 2-10y
Infratentorial
*Juvenile pilocytic astrocytoma
*Medulloblastoma (often supratentorial)
Brain Tumors Location + Type: > 10y
Supratentorial
*Diffuse astrocytoma
Most common brain tumor histology overall:
Astrocytoma
Infratentorial Tumors: Most common and Outcomes
*Astrocytoma most common --> Juvenile pilocytic most common sub-type
*Low grade; rarely invasive
Classic site of Astrocytoma:
Cerebellum
Astrocytoma: Tx
Surgery + Chemo/Rads
Astrocytoma: Survival
80-100% IF COMPLETE RESECTION
Infratentorial Malignant Varieties:
Malignant Astrocytoma (diffuse or fibrillary)
a. Anaplastic
b. Glioblastoma multiform --> Poor outcome
Embryonal Brain tumors Include:
Medullloblastoma (90%)
Medulloblastoma: Ages
Most or males 5-7y
Medulloblastoma: Site
Midline cerebellar vermis (most)
Medulloblastoma: CT findings
Solid, homengenous mass in postieor fossa
Medulloblastoma: Obstructive Complications
*Blocks 4th ventricle --> hydrocephalus --> Vomiting/ICP
Medulloblastoma: Tx / Survival
Chemo-Rads
*60-70% survival
Third Most frequent tumor site?
- Brainstem
Brainstem tumors: Presentation
- Motor weakness, CN deficits, cerebellar deficits (gait), signs of increased ICP
Brainstem tumors: Varieties and outcomes
- Low grade gliomas --> Surgery, OK outcome
- Diffuse intrinsic: Rads, palliative --> Very poor outcome
Brainstem tumors: Survival if diffuse intrinsic
Mean 12 mo
Fourth most common Brain tumor: Name and % overall
Ependymal Tumors (Ependymoma most common) - 10 % overall
Ependymal Tumors: Site
*From ependymal lining of ventricular system
*70% in posterior fossa --> 10% spread
Ependymal Tumors: CT findings
Well circumscribed, generally non-invasive
Ependymal Tumors: Tx
Surgery + Radiation (Chemo OK)
Supratentorial Tumors: Key one to know? % of all?
Craniopharyngioma --> 7-10% = most common supratentorial
Craniopharyngioma: Site
- Suprasellar region
Craniopharyngioma: Aggressiveness
Minimal
Craniopharyngioma: Imaging Findings
Calcification seen on X-Ray
Craniopharyngioma: When to Think of?
- Mass effect findings or --> Decreased growth and child endocrine deficits
Craniopharyngioma: Morbidity
Panhypopituitarism, growth failure, visual loss
Craniopharyngioma: W/u and Tx
- Endocrine studies
- Surgery and Rads --> NO CHEMO

*Hormone replacement after removal
Eye Tumors: Most common
Optic Nerve Gliomas:

*Most frequent tumor of the optic nerve
Optic Nerve Gliomas: Histology
Juvenile pilocytic astrocytoma
Optic Nerve Gliomas: Course
Benign, slowly progressive
Optic Nerve Gliomas: Sx
Unilateral vision loss + Proptosis + Eye deviation

*Optic atrophy
*Nystagmus
*Strabismus
Optic Nerve Gliomas: Genetic Risk?
- Neurofibromatosis
Optic Nerve Gliomas: Tx
*Observation initially

Chiasm: Radiation/Chemo
Surgery --> When confined or unsightly proptosis w/ visual loss or w/ visual deficits